ketotifen has been researched along with Eye Diseases in 3 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Eye Diseases: Diseases affecting the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketotifen an anti-allergic drug delivered via eye drops has major limitations, including poor ocular bioavailability and poor patient compliance." | 1.43 | Extended release of ketotifen from silica shell nanoparticle-laden hydrogel contact lenses: in vitro and in vivo evaluation. ( Koli, AR; Mangukiya, MA; Maulvi, FA; Patel, PA; Ranch, KM; Shah, DO; Vaidya, RJ, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maulvi, FA | 1 |
| Mangukiya, MA | 1 |
| Patel, PA | 1 |
| Vaidya, RJ | 1 |
| Koli, AR | 1 |
| Ranch, KM | 1 |
| Shah, DO | 1 |
| Woerly, G | 1 |
| Loiseau, S | 1 |
| Loyens, M | 1 |
| Schoch, C | 1 |
| Capron, M | 1 |
| Sharif, NA | 1 |
| Xu, SX | 1 |
| Miller, ST | 1 |
| Gamache, DA | 1 |
| Yanni, JM | 1 |
3 other studies available for ketotifen and Eye Diseases
| Article | Year |
|---|---|
Extended release of ketotifen from silica shell nanoparticle-laden hydrogel contact lenses: in vitro and in vivo evaluation.
Topics: Animals; Cell Survival; Contact Lenses; Delayed-Action Preparations; Eye Diseases; Female; Hydrogels | 2016 |
Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases.
Topics: Anti-Allergic Agents; Blood Proteins; Case-Control Studies; Cell Survival; Chemokine CCL11; Chemokin | 2003 |
Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
Topics: Anti-Allergic Agents; Binding, Competitive; Chymases; Conjunctiva; Dibenzoxepins; Eye Diseases; Hist | 1996 |